|
Ascendis Pharma A/S Sponsored Adr
|
06/02
|
222,15
|
+2,19%
|
217,73
|
212,695 - 223,24
|
|
Arvlf
|
07/11
|
0,0001
|
0,00%
|
0,0001
|
0,0001 - 0,0001
|
|
Arvinas
|
06/02
|
13,48
|
+4,01%
|
13,14
|
13,12 - 13,62
|
|
Art's-Way Manufacturing
|
06/02
|
2,35
|
+2,17%
|
2,3
|
2,21 - 2,35
|
|
Artiva Biotherapeutics
|
06/02
|
4,045
|
+4,52%
|
4,05
|
3,9 - 4,13
|
|
Artius Ii Acquisition Inc. Units Consist Of 1 Sh A +
|
26/01
|
10,67
|
0,00%
|
0
|
---
|
|
Artius Ii Acquisition
|
04/02
|
10,33
|
0,00%
|
0
|
---
|
|
Artius Ii Acquisition Inc Rights -For Shares
|
04/02
|
0,33
|
0,00%
|
0
|
---
|
|
Artesian Resources
|
06/02
|
32,31
|
-3,09%
|
33,37
|
32,31 - 33,44
|
|
Arteris
|
06/02
|
14,93
|
+8,90%
|
14,42
|
14,28 - 15,005
|
|
Artelo Biosciences
|
06/02
|
1,47
|
+7,30%
|
1,4
|
1,3546 - 1,51
|
|
Art Technology Acquisition Corp. Units Cons Of
|
06/02
|
9,99
|
-0,05%
|
9,99
|
9,99 - 10
|
|
Ars Pharmaceuticals
|
06/02
|
10,03
|
+3,72%
|
9,87
|
9,7 - 10,05
|
|
Ars Focused Opportunity Strategy Etf
|
06/02
|
37,95
|
+3,59%
|
37,39
|
37,23 - 37,86
|
|
Ars Core Equity Portfolio Etf
|
06/02
|
17,82
|
+2,97%
|
17,7056
|
17,7056 - 17,82
|
|
Arrowmark Financial Corp. Rights For Share
|
06/02
|
0,0651
|
-14,34%
|
0,064
|
0,055 - 0,077
|
|
Arrowmark Financial
|
06/02
|
20,77
|
+2,11%
|
20,41
|
20,1901 - 20,77
|
|
Arrowhead Pharmaceuticals
|
06/02
|
64,56
|
-0,12%
|
65,5
|
63,46 - 68,44
|
|
Arrow Financial
|
06/02
|
36,05
|
+0,75%
|
36,24
|
35,72 - 36,44
|
|
Arrivent Biopharma
|
06/02
|
21,86
|
+2,39%
|
21,86
|
21,42 - 22,36
|